Advertisement
Sarepta Therapeutics, Inc. (SRPT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
As of 02:56PM EST. Market open.
| Previous Close | 114.65 |
| Open | 115.78 |
| Bid | 127.43 x 100 |
| Ask | 128.12 x 100 |
| Day's Range | 115.75 - 128.65 |
| 52 Week Range | 78.67 - 173.25 |
| Volume | |
| Avg. Volume | 884,304 |
| Market Cap | 12.208B |
| Beta (5Y Monthly) | 0.80 |
| PE Ratio (TTM) | 82.99 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Investor's Business Daily
Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 Billion Deal
Shares of Arrowhead Pharmaceuticals catapulted Tuesday after the company inked a broad licensing deal with Sarepta Therapeutics.
- MT Newswires
Arrowhead Pharma, Sarepta Therapeutics Sign Licensing, Partnership Deal for Clinical, Preclinical Programs
Arrowhead Pharmaceuticals (ARWR) and Sarepta Therapeutics (SRPT) have struck a global licensing and partnership deal for clinical and preclinical programs in genetic diseases of the muscle, central nervous system, and lungs, the companies said Tuesday.
- Simply Wall St.
High Growth Tech Stocks to Watch in November 2024
The United States market has remained flat over the last week, yet it has shown significant growth of 31% over the past year with earnings expected to rise by 15% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability, aligning with these positive market trends.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.